Update on X-linked hypogammaglobulinemia with isolated growth hormone deficiency

Current Opinion in Allergy and Clinical Immunology

Volumn 5, Issue 6, 2005, Pages 510-512

  Stewart, Donn M ^a   Tian, Lan ^a   Notarangelo, Luigi D ^b   Nelson, David L ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF BRESCIA   (Italy)

Author keywords

ets family transcription factor; Growth hormone; Hypogammaglobulinemia

Indexed keywords

IMMUNOGLOBULIN; SEX HORMONE; TRANSCRIPTION FACTOR ELF 1;

ARTICLE; CANCER SURGERY; FAMILY; GENE LOCUS; GENE MAPPING; GENE MUTATION; GROWTH HORMONE DEFICIENCY; HETEROZYGOTE; HUMAN; HYPOGAMMAGLOBULINEMIA; LIP TUMOR; NONHUMAN; NUCLEOTIDE SEQUENCE; PEDIGREE; PRIORITY JOURNAL; X CHROMOSOME LINKED DISORDER;

EID: 27944509127     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/01.all.0000191235.35879.29     Document Type: Article

References (14)

1. Fleisher TA, White RM, Broder S, et al. X-linked hypogammaglobulinemia and isolated growth hormone deficiency. N Engl J Med 1980; 302:1429-1434.
2. Yarchoan R, Schneider HS, Wray BB, Nelson DL. Specific anti-influenza virus antibody production in vitro by lymphocytes from a subset of patients with hypogammaglobulinemia. J Clin Invest 1983; 71:1720-1727.
3. Vetrie D, Vorechovsky I, Sideras P, et al. The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases. Nature 1993; 361:226-233.
4. Notarangelo LD, Wagner DK, Schwieterman WD, et al. Restriction fragment polymorphism analysis of patients with X-linked agammaglobulinemia and isolated growth hormone deficiency. In: Albertini A, Paoletti R, Reisfeld RA, editors. Molecular probes: technology and medical applications. New York: Raven Press; 1989. pp. 143-148.
5. Stewart DM, Notarangelo LD, Kurman CC, et al. Molecular genetic analysis of X-linked hypogammaglobulinemia and isolated growth hormone deficiency. J Immunol 1995; 155:2770-2774.
6. Sitz KV, Burks AW, Williams LW, et al. Confirmation of X-linked hypogammaglobulinemia with isolated growth hormone deficiency as a disease entity. J Pediatr 1990; 116:292-294.
7. Conley ME, Burks AW, Herrod HG, Puck JM. Molecular genetic analysis of X-linked agammaglobulinemia with growth hormone deficiency. J Pediatr 1991; 119:392-397.
8. Abo K, Nishio H, Lee MJ, et al. A novel single basepair insertion in exon 6 of the Bruton's tyrosine kinase (Btk) gene from a Japanese X-linked agamma-globulinemia patient with growth hormone insufficiency. Hum Mutat 1998; 11:336.
9. Duriez B, Duquesnoy P, Dastot F, et al. An exon-skipping mutation in the btk gene of a patient with X-linked agammaglobulinemia and isolated growth hormone deficiency. FEBS Lett 1994; 346:165-170.
10. Buzi F, Notarangelo LD, Plebani A, et al. X-linked agammaglobulinemia, growth hormone deficiency and delay of growth and puberty. Acta Paediatr 1994; 83:99-102.
11. Arslan D, Patiroglu T, Kendirci M, Kurtoglu S. X-linked agammaglobulinemia and isolated growth hormone deficiency. Turk J Pediatr 1998; 40:609-612.
12. Miyazaki Y, Sun X, Uchida H, et al. MEF, a novel transcription factor with an Elf-1 like DNA binding domain but distinct transcriptional activating properties. Oncogene 1996; 13:1721-1729.
13. Lacorazza HD, Nimer SD. The emerging role of the myeloid Elf-1 like transcription factor in hematopoiesis. Blood Cells Mol Dis 2003; 31:342-350.
14. Lacorazza HD, Miyazaki Y, Di Cristofano A, et al. The ETS protein MEF plays a critical role in perform gene expression and the development of natural killer and NK-T cells. Immunity 2002; 17:437-449.